Did You Know...
...that one person who claimed to be the inventor of the television is Russian emigre Vladimir Zworykin? In 1929 David Sarnoff, founder of RCA, asked Zworykin what it would take to develop TV for commercial use. He said: a year and a half and $100,000. In reality, it took 20 years and $50 million! Before his death in 1982 at the age of 92, Zworykin said of his invention: "The technique is wonderful. It is beyond my expectations. But the programs! I would never let my children even come close to this thing."
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5441983 | Treatment of infection by enveloped virus with calix(N)arene compounds A method for inhibiting cell infection by an enveloped virus, by administering to an infection site, a therapeutically effective amount of a calix(n)arene compound derivatized, at its ring positions meta to the bridge attachements to the ring, with polar ... | 08/15/1995 |
| 5439925 | Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics Di(aromatic) compounds corresponding to the following formula: ##STR1## in which: Ar represents either ##STR2## n=1 or 2 or: ##STR3## X represents a divalent radical, Z represents O, S or a divalent radical, and R1, R2 | 08/08/1995 |
| 5434180 | Polycyclic aromatic derivatives, process for preparing the same and pharmaceutical and cosmetic compositions containing the same The present invention relates to new polycyclic aromatic derivatives, to processes for their preparation and to their use in therapeutic and cosmetic formulations.... | 07/18/1995 |
| 5434186 | Carboxylic acid leukotriene B4 antagonists Compounds of the formula ##STR1## wherein X is O or CH2 ; Y is O, --CH2 --CH2 --, --CH.dbd.CH--, --C.tbd.C--, or --OCH2 C6 H4 --; Z is --CH2 --CH2 --, --CH.dbd.CH-- or... | 07/18/1995 |
| 5431912 | Cosmetic or dermopharmaceutical composition containing, in combination, a lauroylmethionate of a basic amino acid and at least one polyphenol The present invention addresses a cosmetic or dermopharmaceutical composition comprising, in a suitable vehicle, an antioxidizing system possessing a synergic effect consisting of the combination of laroylmethionate of lysine, histidine or arginine, and o... | 07/11/1995 |
| 5430067 | Pharmaceutical compounds Pharmaceutical compounds as follows: 9,10-dihydro-9,10-dioxo-4,5,8-trimethoxyanthracene-2-carboxylic acid, 4,5-diethoxy-9,10-dihydro-9,10-dioxoanthracene-2-carboxylic acid, 9,10-dihydro-9,10-dioxo-4,5-dipropoxyanthracene-2-carboxylic acid, 4,5-dibutoxy-9,10-dihydro-9,10... | 07/04/1995 |
| 5425938 | Polyamino salts of alpha-hydroxyacids, alpha-ketoacids and related compounds Cosmetic compositions are described wherein -hydroxyacids, -ketoacids and related compounds are formed into amine salts through neutralization with a multi-amine functionalized polymer. Particularly preferred are glycolic acid and lactic aci... | 06/20/1995 |
| 5420161 | Doisynolic acid type compounds as weight and appetite suppressing and control agents The present invention relates to a method of weight and appetite suppression in an animal, including humans, in need of such treatment, by administering an effective amount of the (+), the (-) or the (&#b1;) forms of one of the following compounds or deri... | 05/30/1995 |
| 5405870 | Carbacyclin compounds; pharmaceutical compositions and method of use Compounds of formula (Ic): ##STR1## having valuable platelet-aggregation inhibitory activities useful for the prophylaxis and treatment of such diseases as thrombosis and pharmaceutical compositions containing said compounds.... | 04/11/1995 |
| 5401510 | Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treat... | 03/28/1995 |
| 5401774 | Method for treating patients with precancerous lesions by administering substituted sulfonyl idenyl acetic and propionic acids and esters to patients with lesions sensitive to such compounds Substituted indenyl sulfonyl acetic acids are useful in the treatment of precancerous lesions sensitive to treatment with those sulfonyl compounds.... | 03/28/1995 |
| 5399588 | Naphthalenylmethyl cycloalkenone acetic acids and analogs thereof useful as aldose reductase inhibitors The compounds of this invention which have the formula: ##STR1## wherein: R1 and R2 are independently hydrogen, C1 -C8 alkyl, halogen, C1 -C8 alkoxy, or trifluoromethyl; R3 is --... | 03/21/1995 |
| 5395624 | Depigmenting cosmetic and/or dermatological composition containing a di- or tri-caffeoylquinic acid, or a mixture thereof A depigmenting cosmetic or dermatological composition containing, as active ingredient, at least one di- or tri-caffeoylquinic acid corresponding to general formula (I): ##STR1## in which: R1, R2, R3, and R4 | 03/07/1995 |
| 5387594 | Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics Di(aromatic) compounds corresponding to the following formula: ##STR1## in which: Ar represents either ##STR2## n=1 or 2 or: ##STR3## X represents a divalent radical, Z represents O, S or a divalent radical, and R1, R2... | 02/07/1995 |
| 5385941 | Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms Novel pharmaceutical compositions are comprised of the salt or ion pair formation of a non-steroidal anti-inflammatory drug and an antihistamine or other decongestant. The physico-chemical characteristics of these compositions show them to be substantiall... | 01/31/1995 |
| 5385936 | Gossypol acetic acid for the treatment of cancer A method for treating cancer in a human, which comprises administering to the human subject an anti-cancer effective amount gossypol acetic acid. Also included is a method for treating cancer in a human which comprises administering to the human subject a... | 01/31/1995 |
| 5360820 | Medical use for tachykinin antagonists The present invention relates to the use of tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis. Also described are novel tachykinin antagonists of formula (I), processes for their prepara... | 11/01/1994 |
| 5360611 | Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation Methods for treating the cornea following UV laser irradiation and resulting photoablation of corneal tissue are disclosed. The methods include administration of compositions of a non-steroidal antiinflammatory to the eye. Compositions for use in treating... | 11/01/1994 |
| 5356896 | Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound A pharmaceutical dosage form comprising an HMG-CoA reductase inhibitor compound, e.g., fluvastatin sodium, is disclosed which is stabilized against pH-related degradation by an alkaline stabilizing medium capable of imparting a pH of at least 8 to an aque... | 10/18/1994 |
| 5321043 | Method of combatting transplant rejection The present invention is concerned with methods for the treatment of medical conditions with benzindene prostaglandins. Medical conditions which may be treated by the methods of the present invention include transplant rejection and atherosclerosis.... | 06/14/1994 |
| 5318960 | System for transdermal delivery of pain relieving substances Compositions for pain relieving non-steroidal anti-inflammatory drugs and/or medicaments such as ibuprofen, methotrexate, capsaicin, diphenhydramine, aspirin, methylnicotinate and other medicaments largely soluble in oil, alcohol, and/or water, are produc... | 06/07/1994 |
| 5276053 | Polycyclic amines useful as cerebrovascular agents A novel series of polycyclic amines, derivatives, methods of making the compounds, novel intermediates, compositions containing them, and methods for using them in the treatment and prevention of cerebrovascular disorders are disclosed.... | 01/04/1994 |
| 5271939 | Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treat... | 12/21/1993 |
| 5252344 | Hardening agent for affected tissues of the digestive system The hardening agent contains a composition comprised of tannic acid and potassium aluminum sulfate in a ratio of tannic acid to potassium aluminum sulfate ranging from 10 to 1 to 1 to 50 and a stabilizing agent extracted from crude drugs of plants contain... | 10/12/1993 |
| 5215977 | Method for treating leg weakness in fowl A method of treating poultry suffering from leg bone joint infection and/or leg weakness by administering to the poultry an effective amount of a non-steroidal anti-inflammatory drug and composition of such drug.... | 06/01/1993 |
| 5204370 | Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase C The present invention provides novel substituted anthraquinones having the formula ##STR1## wherein R1 and R2 are independently H, C1 -C10 alkyl, aryl, arylalkyl, alkylaryl; n and m are independently 1, 2, ... | 04/20/1993 |
| 5192753 | Anti-rheumatoid arthritic drugs in the treatment of dementia This invention pertains to the novel use of anti-rheumatoid arthritic drugs in the treatment of dementia. A method of treating dementia in human beings which comprises administering to the human being a therapeutic amount of a non-steroidal anti-inflammat... | 03/09/1993 |
| 5190972 | Method of combatting cyclosporine organ toxicity with prostaglandin analogs The present invention is concerned with methods for the treatment of medical conditions with benzindene prostaglandins. Medical conditions which may be treated by the methods of the present invention include transplant rejection and atherosclerosis.... | 03/02/1993 |
| 5177108 | Aryloxy alkanols as anti-retrovirus agents Aryloxyalkanol derivatives having the formula Ar--O(CH2)n OH wherein n is an integer from 3 to 8 and Ar is (1) 1- or 2-naphthylenyl, (2) phenyl optionally substituted by from 1 to 3 C1-4 lower alkyl groups, or (3) a diphenyl mo... | 01/05/1993 |
| 5162353 | Carbacyclins, processes for their preparation, and their use as medicinal agents The invention relates to carbacyclin derivatives with general formula I: ##STR1## in which Y1 stands for the radical --CH2 --X--(CH2)n --R1 or the radical ##STR2## n, 1 or 3, R1, ... | 11/10/1992 |
| 5158977 | Cosmetic and pharmaceutical compositions containing naphthalenol derivatives A 5,6,7,8-tetrahydro-1-naphthalenol derivative of the formula ##STR1## wherein R1, R2, R3 and R4 represent lower alkyl, R5 and R6 represent hydrogen or lower alkyl, R represents hydrogen, C... | 10/27/1992 |
| 5153227 | Phenylsulfonyl nitromethanes as aldose reductase inhibitors The invention concerns novel pharmaceutical compositions for use in the treatment of certain complications of diabetes and galactosemia and which contain a nitromethane derivative (or its non-toxic salt) as active ingredient. The nitromethane derivatives ... | 10/06/1992 |
| 5141937 | 7-diphenylmethylenebicycloheptane or 7-diphenylmethylenebicylcoheptene derivatives Pharmaceutical products containing a 7-diphenylmethylenebicycloheptane or 7-diphenylmethylenebicycloheptene derivative of the formula I ##STR1## in which A, B, R1, R2, R3 and R4 have the stated meanings, or... | 08/25/1992 |
| 5128373 | Packages containing injectable formulations of the sodium salt of naproxen Aqueous stable injectable formulations containing the sodium salt of naproxen, stabilizing agents and polyhydroxylic alcohols, packaged in containers made up of boxes of polystyrene or of an equivalent material covered with films which absorb the light ra... | 07/07/1992 |
| 5126371 | Diarylacetylenes, their preparation and their use Novel diarylacetylenes of the formula I ##STR1## where A, R1, R2, R3, R4, R5 and R6 have the meanings stated in the description, are useful for the treatment of disorders.... | 06/30/1992 |
| 5106407 | Iodones and methods for antimicrobial use The present invention discloses the antimicrobial utility of certain iodonium ylide compounds. The particular iodonium ylide compounds are phenyl iodonium ylides having an ortho substituent that stabilizes the positive charge on the polyvalent iodine by a... | 04/21/1992 |
| 5098895 | Benzonaphthalene derivatives, a process for their preparation and their use in therapeutic and cosmetic compositions A benzonaphthalene compound has the formula ##STR1## wherein R1 represents ##STR2## or (ii) --CH2 OH; R6 represents ##STR3## or OR7 wherein R7 represents hydrogen, alkyl having 1-20 car... | 03/24/1992 |
| 5096926 | Injectable formulations containing the sodium salt of naproxen Aqueous stable injectable formulations containing the sodium salt of naproxen, stabilizing agents and polyhydroxylic alcohols, packaged in containers made up of boxes of polystyrene or of an equivalent material covered with films which absorb the light ra... | 03/17/1992 |
| 5091418 | Novel alpha-glucosidase inhibitor, pradimicin Q The present invention relates to a novel -glucosidase inhibitor, pradimicin Q, having the following formula ##STR1## and its pharmaceutically acceptable base salts.... | 02/25/1992 |
| 5079245 | 2-trifluoromethyl-7-substitute-6,7,8,9-tetrahydro-[5H]-benzocycloheptenes The compounds 2-trifluoromethyl-7-substituted-6,7,8,9-tetrahydro-[5H]-benzocycloheptenes are disclosed and disclosed to be useful in the treatment of metabolic illnesses such as diabetes, obesity, and their complications. A perferred compound is ... | 01/07/1992 |
